Oric Pharmaceuticals Cash Flow Statement (2019-2026) | ORIC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-21.04M	-18.43M	-22.77M	-23.16M	-20.70M	-25.69M	-20.85M	-23.95M	-24.99M	-28.68M	-31.43M	-28.99M	-36.02M	-38.32M	-39.57M	-32.72M	-39.06M	-36.67M	-34.55M	-39.62M
Depreciation and Depletion (Quarter)	0.22M	0.22M	0.23M	0.25M	0.25M	0.22M	0.28M	0.25M	0.26M	0.26M	0.23M	0.26M	0.27M	0.27M	0.30M	0.30M	0.31M	0.29M	0.32M	0.27M
Share-based Compensation (Quarter)	3.21M	3.40M	3.50M	3.94M	4.09M	3.29M	3.13M	3.61M	3.83M	3.86M	3.92M	4.96M	5.00M	5.06M	5.20M	6.55M	6.57M	5.63M	6.28M	6.90M
Gains from Sales and Divestitures (Quarter)							0.07M	0.00M	0.01M	0.01M	0.18M	0.00M	0.01M	0.02M	0.31M	0.00M	0.02M	0.04M	0.40M	0.01M
Gains from Investment Securities (Quarter)	5.21M	1.53M	5.27M	6.42M	1.76M	4.82M	6.69M	1.80M	1.93M	0.04M	8.72M	10.82M	2.53M	0.24M	11.25M	2.95M	0.05M	3.45M	13.90M	3.36M
Non-cash Items (Quarter)	36.06M	47.73M	2.32M	5.49M	4.45M	1.67M	14.14M	12.93M	29.50M	3.38M	41.69M	4.52M	23.10M	5.44M	31.11M	6.97M	7.75M	80.30M	30.73M	99.60M
Cash from Operations (Quarter)	-16.21M	-12.14M	-16.28M	-22.72M	-17.78M	-19.32M	-15.33M	-20.63M	-21.14M	-19.64M	-24.27M	-30.19M	-25.62M	-28.80M	-28.05M	-32.53M	-30.84M	-25.11M	-22.48M	-32.44M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.43M	-0.33M	-0.15M	-0.04M	0.09M	0.37M	0.62M	0.86M	1.26M	1.92M	2.12M	2.23M	2.30M	1.95M	1.63M	0.88M	0.59M	0.59M	0.24M	-0.16M
Depreciation & Amortization (CF) (Quarter)	0.22M	0.22M	0.23M	0.25M	0.25M	0.22M	0.28M	0.25M	0.26M	0.26M	0.23M	0.26M	0.27M	0.27M	0.30M	0.30M	0.31M	0.29M	0.32M	0.27M
Change in Working Capital
Change in Accured Expenses (Quarter)	2.05M	1.64M	2.48M	-3.26M	-0.16M	0.50M	1.44M	-0.79M	-0.82M	3.91M	0.98M	-5.76M	3.80M	0.76M	3.03M	-7.91M	-0.25M	1.36M	-0.45M	-3.32M
Other Working Capital Changes (Quarter)	1.12M	-0.70M	-0.13M	0.54M	1.58M	-1.86M	-1.28M	-1.10M	0.21M	0.28M	-1.00M	2.41M	0.43M	-1.63M	-1.35M	0.57M	0.53M	-0.78M	-2.11M	0.68M
Investing Activities
Capital Expenditures (Quarter)	0.14M	0.23M	0.39M	0.72M	0.67M	0.40M	0.29M	0.31M	0.41M	0.08M	0.06M	0.22M	0.33M	0.42M	0.22M	0.39M	0.06M	0.04M	0.23M	0.00M
Change in Acquisitions & Divestments (Quarter)	82.50M	43.00M	37.50M	10.00M		60.73M	60.22M	56.48M	36.99M	53.23M	49.99M	52.74M	67.50M	77.50M	77.50M	87.50M	47.50M	55.00M	62.50M	60.00M
Cash from Investing Activities (Quarter)	82.36M	35.07M	0.35M	-90.66M	-46.20M	-0.69M	28.30M	12.78M	-19.31M	-57.83M	20.96M	-61.87M	18.28M	23.07M	42.66M	22.45M	-76.93M	-110.53M	16.98M	-17.98M
Financing Activities
Other financing activities (Quarter)												0.17M					0.66M	1.74M		0.99M
Cash from Financing Activities (Quarter)	-0.28M	48.59M	0.81M	0.02M	0.41M	0.00M	24.79M		85.17M	0.03M	0.45M	125.03M	0.82M	0.13M	0.57M	0.01M	134.30M	109.45M	1.50M	61.14M
Additional items
Change in Cash (Quarter)	65.87M	71.52M	-15.12M	113.36M	-290.29M	-20.00M	37.76M	-7.85M	44.72M	-77.44M	-2.85M	32.98M	-6.53M	-5.60M	15.18M	-10.07M	26.53M	-26.20M	-4.00M	10.73M
Free Cash Flow (Quarter)	-16.35M	-12.38M	-16.67M	-23.44M	-18.44M	-19.72M	-15.62M	-20.94M	-21.55M	-19.72M	-24.33M	-30.40M	-25.96M	-29.21M	-28.27M	-32.92M	-30.91M	-25.15M	-22.71M	-32.44M
Net Cash Flow (Quarter)	65.87M	71.52M	-15.12M	-113.36M	-63.56M	-20.00M	37.76M	-7.85M	44.72M	-77.44M	-2.85M	32.98M	-6.53M	-5.60M	15.18M	-10.07M	26.53M	-26.20M	-4.00M	10.73M

Research Tools

Developers

Oric Pharmaceuticals Cash Flow Statement (2019-2026) | ORIC

Research Tools

Developers

Oric Pharmaceuticals Cash Flow Statement (2019-2026) | ORIC

Create an account

Sign In

Reset Password